天泓文創(08500.HK)淨籌約3190萬港元 預期1月14日上市
格隆匯1月13日丨天泓文創(08500.HK)公佈,發售4500萬股,其中公開發售1350萬股,配售3150萬股;發售價每股1.39港元;每手2,000股;預期1月14日上市。
公告顯示,公開發售獲適度超額認購,相當於根據公開發售初步可供認購股份總數的約15.1倍。
據悉,配售獲輕微超額認購,相當於配售項下初步可供認購配售股份總數的約1.15倍。
公告稱,所得款項淨額估計約為3190萬港元。其中約54.6%用於通過獲取額外資源以擴大專有户外及網上廣告資源的覆蓋範圍;約29.0%用於擴大業務範圍至增長中地區及擴大所提供服務範圍;約6.4%用於擴大大數據平台;約10.0%用於作營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.